English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 110 | Tables: 107 | Pharma & Healthcare
The global market for Wound Care Biologics was valued at US$ 4821 million in the year 2024 and is projected to reach a revised size of US$ 9726 million by 2031, growing at a CAGR of 10.7% during the forecast period.
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
The wound care biologics market is experiencing significant growth and is expected to continue to expand in the coming years driven by the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, as well as the growing geriatric population. The major sales regions for wound care biologics include North America, Europe, Asia Pacific, and Latin America. North America currently holds the largest market share, due to the presence of a well-established healthcare infrastructure and high adoption rates of advanced wound care products. Europe is also a key market for wound care biologics, with countries like Germany and the UK leading the way in terms of market penetration.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent. In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Despite the promising growth prospects, the wound care biologics market also faces several challenges. One of the key challenges is the high cost of biologics, which can limit access to these advanced wound care treatments for some patients. Additionally, regulatory hurdles and reimbursement issues can also pose challenges for companies operating in this space. However, there are also several opportunities for growth in the wound care biologics market. The increasing focus on personalized medicine and the development of novel biologic therapies are expected to drive market growth in the coming years. Additionally, the rising awareness about the benefits of biologics in wound healing and the growing demand for advanced wound care products in emerging markets present new opportunities for market expansion.
This report aims to provide a comprehensive presentation of the global market for Wound Care Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Care Biologics.
The Wound Care Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wound Care Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wound Care Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Smith and Nephew
Orthofix Medical
Organogenesis
MiMedx
Integra
Integra LifeSciences
Celularity
Amnio Technology, LLC
Skye Biologics
Pinnacle Transplant Technologies
Convatec Group
Stryker Corporation
LifeNet Health
Coloplast
Tides Medical
Imbed Biosciences
NeXtGen Biologics
Life Biologics
Royal Biologics
Merakris Therapeutics
MediWound
Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wound Care Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wound Care Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologic Skin Substitutes
1.2.3 Enzyme Based Formulations
1.2.4 Growth Factors
1.3 Market by Application
1.3.1 Global Wound Care Biologics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Wounds
1.3.3 Chronic Wounds
1.3.4 Surgical Wounds
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Wound Care Biologics Market Perspective (2020-2031)
2.2 Global Wound Care Biologics Growth Trends by Region
2.2.1 Global Wound Care Biologics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Wound Care Biologics Historic Market Size by Region (2020-2025)
2.2.3 Wound Care Biologics Forecasted Market Size by Region (2026-2031)
2.3 Wound Care Biologics Market Dynamics
2.3.1 Wound Care Biologics Industry Trends
2.3.2 Wound Care Biologics Market Drivers
2.3.3 Wound Care Biologics Market Challenges
2.3.4 Wound Care Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Wound Care Biologics Players by Revenue
3.1.1 Global Top Wound Care Biologics Players by Revenue (2020-2025)
3.1.2 Global Wound Care Biologics Revenue Market Share by Players (2020-2025)
3.2 Global Wound Care Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Wound Care Biologics Revenue
3.4 Global Wound Care Biologics Market Concentration Ratio
3.4.1 Global Wound Care Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wound Care Biologics Revenue in 2024
3.5 Global Key Players of Wound Care Biologics Head office and Area Served
3.6 Global Key Players of Wound Care Biologics, Product and Application
3.7 Global Key Players of Wound Care Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Wound Care Biologics Breakdown Data by Type
4.1 Global Wound Care Biologics Historic Market Size by Type (2020-2025)
4.2 Global Wound Care Biologics Forecasted Market Size by Type (2026-2031)
5 Wound Care Biologics Breakdown Data by Application
5.1 Global Wound Care Biologics Historic Market Size by Application (2020-2025)
5.2 Global Wound Care Biologics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Wound Care Biologics Market Size (2020-2031)
6.2 North America Wound Care Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Wound Care Biologics Market Size by Country (2020-2025)
6.4 North America Wound Care Biologics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Wound Care Biologics Market Size (2020-2031)
7.2 Europe Wound Care Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Wound Care Biologics Market Size by Country (2020-2025)
7.4 Europe Wound Care Biologics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Wound Care Biologics Market Size (2020-2031)
8.2 Asia-Pacific Wound Care Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Wound Care Biologics Market Size by Region (2020-2025)
8.4 Asia-Pacific Wound Care Biologics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Wound Care Biologics Market Size (2020-2031)
9.2 Latin America Wound Care Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Wound Care Biologics Market Size by Country (2020-2025)
9.4 Latin America Wound Care Biologics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Wound Care Biologics Market Size (2020-2031)
10.2 Middle East & Africa Wound Care Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Wound Care Biologics Market Size by Country (2020-2025)
10.4 Middle East & Africa Wound Care Biologics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Smith and Nephew
11.1.1 Smith and Nephew Company Details
11.1.2 Smith and Nephew Business Overview
11.1.3 Smith and Nephew Wound Care Biologics Introduction
11.1.4 Smith and Nephew Revenue in Wound Care Biologics Business (2020-2025)
11.1.5 Smith and Nephew Recent Development
11.2 Orthofix Medical
11.2.1 Orthofix Medical Company Details
11.2.2 Orthofix Medical Business Overview
11.2.3 Orthofix Medical Wound Care Biologics Introduction
11.2.4 Orthofix Medical Revenue in Wound Care Biologics Business (2020-2025)
11.2.5 Orthofix Medical Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Details
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Wound Care Biologics Introduction
11.3.4 Organogenesis Revenue in Wound Care Biologics Business (2020-2025)
11.3.5 Organogenesis Recent Development
11.4 MiMedx
11.4.1 MiMedx Company Details
11.4.2 MiMedx Business Overview
11.4.3 MiMedx Wound Care Biologics Introduction
11.4.4 MiMedx Revenue in Wound Care Biologics Business (2020-2025)
11.4.5 MiMedx Recent Development
11.5 Integra
11.5.1 Integra Company Details
11.5.2 Integra Business Overview
11.5.3 Integra Wound Care Biologics Introduction
11.5.4 Integra Revenue in Wound Care Biologics Business (2020-2025)
11.5.5 Integra Recent Development
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Details
11.6.2 Integra LifeSciences Business Overview
11.6.3 Integra LifeSciences Wound Care Biologics Introduction
11.6.4 Integra LifeSciences Revenue in Wound Care Biologics Business (2020-2025)
11.6.5 Integra LifeSciences Recent Development
11.7 Celularity
11.7.1 Celularity Company Details
11.7.2 Celularity Business Overview
11.7.3 Celularity Wound Care Biologics Introduction
11.7.4 Celularity Revenue in Wound Care Biologics Business (2020-2025)
11.7.5 Celularity Recent Development
11.8 Amnio Technology, LLC
11.8.1 Amnio Technology, LLC Company Details
11.8.2 Amnio Technology, LLC Business Overview
11.8.3 Amnio Technology, LLC Wound Care Biologics Introduction
11.8.4 Amnio Technology, LLC Revenue in Wound Care Biologics Business (2020-2025)
11.8.5 Amnio Technology, LLC Recent Development
11.9 Skye Biologics
11.9.1 Skye Biologics Company Details
11.9.2 Skye Biologics Business Overview
11.9.3 Skye Biologics Wound Care Biologics Introduction
11.9.4 Skye Biologics Revenue in Wound Care Biologics Business (2020-2025)
11.9.5 Skye Biologics Recent Development
11.10 Pinnacle Transplant Technologies
11.10.1 Pinnacle Transplant Technologies Company Details
11.10.2 Pinnacle Transplant Technologies Business Overview
11.10.3 Pinnacle Transplant Technologies Wound Care Biologics Introduction
11.10.4 Pinnacle Transplant Technologies Revenue in Wound Care Biologics Business (2020-2025)
11.10.5 Pinnacle Transplant Technologies Recent Development
11.11 Convatec Group
11.11.1 Convatec Group Company Details
11.11.2 Convatec Group Business Overview
11.11.3 Convatec Group Wound Care Biologics Introduction
11.11.4 Convatec Group Revenue in Wound Care Biologics Business (2020-2025)
11.11.5 Convatec Group Recent Development
11.12 Stryker Corporation
11.12.1 Stryker Corporation Company Details
11.12.2 Stryker Corporation Business Overview
11.12.3 Stryker Corporation Wound Care Biologics Introduction
11.12.4 Stryker Corporation Revenue in Wound Care Biologics Business (2020-2025)
11.12.5 Stryker Corporation Recent Development
11.13 LifeNet Health
11.13.1 LifeNet Health Company Details
11.13.2 LifeNet Health Business Overview
11.13.3 LifeNet Health Wound Care Biologics Introduction
11.13.4 LifeNet Health Revenue in Wound Care Biologics Business (2020-2025)
11.13.5 LifeNet Health Recent Development
11.14 Coloplast
11.14.1 Coloplast Company Details
11.14.2 Coloplast Business Overview
11.14.3 Coloplast Wound Care Biologics Introduction
11.14.4 Coloplast Revenue in Wound Care Biologics Business (2020-2025)
11.14.5 Coloplast Recent Development
11.15 Tides Medical
11.15.1 Tides Medical Company Details
11.15.2 Tides Medical Business Overview
11.15.3 Tides Medical Wound Care Biologics Introduction
11.15.4 Tides Medical Revenue in Wound Care Biologics Business (2020-2025)
11.15.5 Tides Medical Recent Development
11.16 Imbed Biosciences
11.16.1 Imbed Biosciences Company Details
11.16.2 Imbed Biosciences Business Overview
11.16.3 Imbed Biosciences Wound Care Biologics Introduction
11.16.4 Imbed Biosciences Revenue in Wound Care Biologics Business (2020-2025)
11.16.5 Imbed Biosciences Recent Development
11.17 NeXtGen Biologics
11.17.1 NeXtGen Biologics Company Details
11.17.2 NeXtGen Biologics Business Overview
11.17.3 NeXtGen Biologics Wound Care Biologics Introduction
11.17.4 NeXtGen Biologics Revenue in Wound Care Biologics Business (2020-2025)
11.17.5 NeXtGen Biologics Recent Development
11.18 Life Biologics
11.18.1 Life Biologics Company Details
11.18.2 Life Biologics Business Overview
11.18.3 Life Biologics Wound Care Biologics Introduction
11.18.4 Life Biologics Revenue in Wound Care Biologics Business (2020-2025)
11.18.5 Life Biologics Recent Development
11.19 Royal Biologics
11.19.1 Royal Biologics Company Details
11.19.2 Royal Biologics Business Overview
11.19.3 Royal Biologics Wound Care Biologics Introduction
11.19.4 Royal Biologics Revenue in Wound Care Biologics Business (2020-2025)
11.19.5 Royal Biologics Recent Development
11.20 Merakris Therapeutics
11.20.1 Merakris Therapeutics Company Details
11.20.2 Merakris Therapeutics Business Overview
11.20.3 Merakris Therapeutics Wound Care Biologics Introduction
11.20.4 Merakris Therapeutics Revenue in Wound Care Biologics Business (2020-2025)
11.20.5 Merakris Therapeutics Recent Development
11.21 MediWound
11.21.1 MediWound Company Details
11.21.2 MediWound Business Overview
11.21.3 MediWound Wound Care Biologics Introduction
11.21.4 MediWound Revenue in Wound Care Biologics Business (2020-2025)
11.21.5 MediWound Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Wound Care Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biologic Skin Substitutes
Table 3. Key Players of Enzyme Based Formulations
Table 4. Key Players of Growth Factors
Table 5. Global Wound Care Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Wound Care Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Wound Care Biologics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Wound Care Biologics Market Share by Region (2020-2025)
Table 9. Global Wound Care Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Wound Care Biologics Market Share by Region (2026-2031)
Table 11. Wound Care Biologics Market Trends
Table 12. Wound Care Biologics Market Drivers
Table 13. Wound Care Biologics Market Challenges
Table 14. Wound Care Biologics Market Restraints
Table 15. Global Wound Care Biologics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Wound Care Biologics Market Share by Players (2020-2025)
Table 17. Global Top Wound Care Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wound Care Biologics as of 2024)
Table 18. Ranking of Global Top Wound Care Biologics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Wound Care Biologics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Wound Care Biologics, Headquarters and Area Served
Table 21. Global Key Players of Wound Care Biologics, Product and Application
Table 22. Global Key Players of Wound Care Biologics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Wound Care Biologics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Wound Care Biologics Revenue Market Share by Type (2020-2025)
Table 26. Global Wound Care Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Wound Care Biologics Revenue Market Share by Type (2026-2031)
Table 28. Global Wound Care Biologics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Wound Care Biologics Revenue Market Share by Application (2020-2025)
Table 30. Global Wound Care Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Wound Care Biologics Revenue Market Share by Application (2026-2031)
Table 32. North America Wound Care Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Wound Care Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Wound Care Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Wound Care Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Wound Care Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Wound Care Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Wound Care Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Wound Care Biologics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Wound Care Biologics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Wound Care Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Wound Care Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Wound Care Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Wound Care Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Wound Care Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Wound Care Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Smith and Nephew Company Details
Table 48. Smith and Nephew Business Overview
Table 49. Smith and Nephew Wound Care Biologics Product
Table 50. Smith and Nephew Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 51. Smith and Nephew Recent Development
Table 52. Orthofix Medical Company Details
Table 53. Orthofix Medical Business Overview
Table 54. Orthofix Medical Wound Care Biologics Product
Table 55. Orthofix Medical Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 56. Orthofix Medical Recent Development
Table 57. Organogenesis Company Details
Table 58. Organogenesis Business Overview
Table 59. Organogenesis Wound Care Biologics Product
Table 60. Organogenesis Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 61. Organogenesis Recent Development
Table 62. MiMedx Company Details
Table 63. MiMedx Business Overview
Table 64. MiMedx Wound Care Biologics Product
Table 65. MiMedx Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 66. MiMedx Recent Development
Table 67. Integra Company Details
Table 68. Integra Business Overview
Table 69. Integra Wound Care Biologics Product
Table 70. Integra Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 71. Integra Recent Development
Table 72. Integra LifeSciences Company Details
Table 73. Integra LifeSciences Business Overview
Table 74. Integra LifeSciences Wound Care Biologics Product
Table 75. Integra LifeSciences Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 76. Integra LifeSciences Recent Development
Table 77. Celularity Company Details
Table 78. Celularity Business Overview
Table 79. Celularity Wound Care Biologics Product
Table 80. Celularity Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 81. Celularity Recent Development
Table 82. Amnio Technology, LLC Company Details
Table 83. Amnio Technology, LLC Business Overview
Table 84. Amnio Technology, LLC Wound Care Biologics Product
Table 85. Amnio Technology, LLC Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 86. Amnio Technology, LLC Recent Development
Table 87. Skye Biologics Company Details
Table 88. Skye Biologics Business Overview
Table 89. Skye Biologics Wound Care Biologics Product
Table 90. Skye Biologics Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 91. Skye Biologics Recent Development
Table 92. Pinnacle Transplant Technologies Company Details
Table 93. Pinnacle Transplant Technologies Business Overview
Table 94. Pinnacle Transplant Technologies Wound Care Biologics Product
Table 95. Pinnacle Transplant Technologies Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 96. Pinnacle Transplant Technologies Recent Development
Table 97. Convatec Group Company Details
Table 98. Convatec Group Business Overview
Table 99. Convatec Group Wound Care Biologics Product
Table 100. Convatec Group Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 101. Convatec Group Recent Development
Table 102. Stryker Corporation Company Details
Table 103. Stryker Corporation Business Overview
Table 104. Stryker Corporation Wound Care Biologics Product
Table 105. Stryker Corporation Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 106. Stryker Corporation Recent Development
Table 107. LifeNet Health Company Details
Table 108. LifeNet Health Business Overview
Table 109. LifeNet Health Wound Care Biologics Product
Table 110. LifeNet Health Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 111. LifeNet Health Recent Development
Table 112. Coloplast Company Details
Table 113. Coloplast Business Overview
Table 114. Coloplast Wound Care Biologics Product
Table 115. Coloplast Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 116. Coloplast Recent Development
Table 117. Tides Medical Company Details
Table 118. Tides Medical Business Overview
Table 119. Tides Medical Wound Care Biologics Product
Table 120. Tides Medical Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 121. Tides Medical Recent Development
Table 122. Imbed Biosciences Company Details
Table 123. Imbed Biosciences Business Overview
Table 124. Imbed Biosciences Wound Care Biologics Product
Table 125. Imbed Biosciences Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 126. Imbed Biosciences Recent Development
Table 127. NeXtGen Biologics Company Details
Table 128. NeXtGen Biologics Business Overview
Table 129. NeXtGen Biologics Wound Care Biologics Product
Table 130. NeXtGen Biologics Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 131. NeXtGen Biologics Recent Development
Table 132. Life Biologics Company Details
Table 133. Life Biologics Business Overview
Table 134. Life Biologics Wound Care Biologics Product
Table 135. Life Biologics Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 136. Life Biologics Recent Development
Table 137. Royal Biologics Company Details
Table 138. Royal Biologics Business Overview
Table 139. Royal Biologics Wound Care Biologics Product
Table 140. Royal Biologics Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 141. Royal Biologics Recent Development
Table 142. Merakris Therapeutics Company Details
Table 143. Merakris Therapeutics Business Overview
Table 144. Merakris Therapeutics Wound Care Biologics Product
Table 145. Merakris Therapeutics Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 146. Merakris Therapeutics Recent Development
Table 147. MediWound Company Details
Table 148. MediWound Business Overview
Table 149. MediWound Wound Care Biologics Product
Table 150. MediWound Revenue in Wound Care Biologics Business (2020-2025) & (US$ Million)
Table 151. MediWound Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 155. Authors List of This Report
List of Figures
Figure 1. Wound Care Biologics Picture
Figure 2. Global Wound Care Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Wound Care Biologics Market Share by Type: 2024 VS 2031
Figure 4. Biologic Skin Substitutes Features
Figure 5. Enzyme Based Formulations Features
Figure 6. Growth Factors Features
Figure 7. Global Wound Care Biologics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Wound Care Biologics Market Share by Application: 2024 VS 2031
Figure 9. Acute Wounds Case Studies
Figure 10. Chronic Wounds Case Studies
Figure 11. Surgical Wounds Case Studies
Figure 12. Wound Care Biologics Report Years Considered
Figure 13. Global Wound Care Biologics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Wound Care Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Wound Care Biologics Market Share by Region: 2024 VS 2031
Figure 16. Global Wound Care Biologics Market Share by Players in 2024
Figure 17. Global Top Wound Care Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wound Care Biologics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Wound Care Biologics Revenue in 2024
Figure 19. North America Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Wound Care Biologics Market Share by Country (2020-2031)
Figure 21. United States Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Wound Care Biologics Market Share by Country (2020-2031)
Figure 25. Germany Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Wound Care Biologics Market Share by Region (2020-2031)
Figure 33. China Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Wound Care Biologics Market Share by Country (2020-2031)
Figure 41. Mexico Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Wound Care Biologics Market Share by Country (2020-2031)
Figure 45. Turkey Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Wound Care Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Smith and Nephew Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 49. Orthofix Medical Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 50. Organogenesis Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 51. MiMedx Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 52. Integra Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 53. Integra LifeSciences Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 54. Celularity Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 55. Amnio Technology, LLC Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 56. Skye Biologics Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 57. Pinnacle Transplant Technologies Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 58. Convatec Group Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 59. Stryker Corporation Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 60. LifeNet Health Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 61. Coloplast Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 62. Tides Medical Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 63. Imbed Biosciences Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 64. NeXtGen Biologics Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 65. Life Biologics Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 66. Royal Biologics Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 67. Merakris Therapeutics Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 68. MediWound Revenue Growth Rate in Wound Care Biologics Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
